Data / Form D filings / Avidity Biosciences, Inc.
Avidity Biosciences, Inc.: Form D filings
Avidity Biosciences, Inc., a biotechnology company in San Diego, CA, filed 5 Form D notices with the SEC between 2014 and 2024. The latest, on March 19, 2024, reports $400.2 million sold of a $400.2 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10578 Science Center Drive, Suite 125, San Diego, CA, 92121
- Phone
- (858) 401-7900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1599901
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | New notice | $400,208,765 | $400,208,765 | 45 | Mar 4, 2024 | sec.gov | |
| Nov 13, 2019 | New notice | $103,803,086 | $100,503,090 | $3,299,996 | 28 | Nov 8, 2019 | sec.gov |
| Jan 6, 2017 | New notice | $23,313,577 | $17,971,847 | $5,341,730 | 21 | Dec 21, 2016 | sec.gov |
| Feb 18, 2014 | Amendment | $9,067,850 | $9,067,850 | 36 | Jan 31, 2014 | sec.gov | |
| Feb 18, 2014 | New notice | $9,067,850 | $9,067,850 | 36 | Jan 31, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Noreen Michael Henig | Director | |
| Carsten Michael Boess | Director | |
| Troy Michael Wilson | Director | |
| Tamar Michael Thompson | Director | |
| Sarah Boyce | Executive Officer, Director | |
| Teresa Michael McCarthy | Executive Officer | |
| Edward Michael Kaye | Director | |
| Jean Michael Kim | Director | |
| W. Michael Flanagan | Executive Officer | |
| Arthur Levin | Executive Officer | |
| Michael Michael MacLean | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avidity Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.